相关实验视频

Updated: Jul 20, 2025

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

一种需要与转移性宫癌区分的初级肺癌病例

Yoko Kataoka^1,2, Takuya Fujita², Kentaro Fukunaga³

¹Department of Surgery Shiga University of Medical Science Otsu Japan.

Respirology case reports

|August 3, 2023

概括

p16蛋白是人类乳头瘤病毒 (HPV) 相关的宫瘤的标志物,但并不总是肺部瘤. 一个案例研究表明,患有宫癌的患者患有负p16肺瘤,被诊断为原发性肺癌.

科学领域:

在瘤学瘤学.
病理学病理学病理学
肺部病理学肺部病理学

背景情况:

p16蛋白是人类乳头瘤病毒 (HPV) 驱动的癌症,特别是宫平细胞癌的验证生物标志物.
它作为肺恶性瘤的标记物的实用性,特别是在将转移性与原发性肺瘤区分开来时,仍然不太了解.

研究的目的:

调查p16表达在区分肺瘤的作用,患者有HPV相关的宫癌史.
报道一项案例研究,突出诊断的挑战,在一个病人与同步的宫和肺状细胞癌.

主要方法:

一个80岁的女性病例介绍,她有宫癌史和新发现的左肺瘤.
在宫和肺瘤中,诊断程序包括支气管透镜活检和针对p16表达的免疫组织化学染色.

主要成果:

子宫瘤显示出强烈的p16阳性,与HPV相关的恶性瘤一致.
肺部瘤表现出负的p16染色,并且在组织学上被确定为带有乳头图案的状细胞癌.
根据p16状态和组织学,肺部瘤被诊断为原发性肺癌,而不是从子宫转移.

结论:

肺瘤中的p16阴性,尽管有p16阳性宫癌的病史,支持初级肺癌的诊断.
对p16的免疫组织化学分析对于在有HPV相关恶性瘤病史的患者中对肺结节的差异诊断至关重要.

关键词:

这是一个HPVHPVHPV.肺癌是一种肺癌.p16 p16 在这个问题上.乳头瘤病毒的病毒状细胞癌的癌症.

更多相关视频

Acellular and Cellular Lung Model to Study Tumor Metastasis

Acellular and Cellular Lung Model to Study Tumor Metastasis

Published on: August 19, 2018

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...